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ABSTRACT 
DE-DIFFERENTIATION OF PAROTID ACINAR CELLS IN VITRO 
Andrew S. Currie 
July 16, 2010 
Background: When rat salivary gland cells are cultured in vitro, they de-
differentiate within 24 h. 
Hypothesis: Growth factors will prevent de-differentiation of primary cultures of 
parotid gland cells, and they will induce differentiation of ParC5 cells. DNA 
methylation drives de-differentiation and the loss of expression in cultured parotid 
cells. 
Methods: Rat parotid glands were collected and cultured in media using different 
combinations of growth factors. DNA was evaluated for methylation at various 
time points. 
Results: No media tested prevented the de-differentiation of parotid cells, and 
none induced differentiation of ParC5 cells. Limited variation in methylation of 
CpG sites was seen. 
Conclusion: Growth factors do not prevent de-differentiation in primary cell 
culture, nor do they activate differentiation in ParC5 cells. Global methylation of 
Mist1 does not cause de-differentiation; evidence supports that methylation of 
PSP increases over time. 
iv 
TABLE OF CONTENTS 
Page 
ACKNOWLEDGEMENTS ........................................................................ iii 
ABSTRACT PART I ................................................................................. iv 
LIST OF FIGURES ................................................................................. vi 
LIST OF TABLES .................................................................................. vii 
CHAPTER 
I. INTRODUCTION-PART I. .................................................................... 1 
II: METHODS AND MATERIALS- PART 1. ................................................. 10 
III: RESUL TS- PART I. .......................................................................... 14 
IV: DISCUSSION- PART I. ..................................................................... 27 
V: INTRODUCTION-PART II .................................................................. 30 
VI: METHODS AND MATERIALS- PART II ................................................ 35 
VII: RESUL TS- PART II ........................................................................... .41 
VIII: DISCUSSION- PART II ................................................................... 57 
REFERENCES .................................................................................... 63 
LIST OF ABBREViATIONS .................................................................... 68 
CURRICULUM ViTAE ........................................................................... 69 
v 
LIST OF FIGURES 
FIGURE PAGE 
1. Expression of Amylase, Mist1, and PSP mRNAs in primary parotid cell 
cultures ................................................................................... 15 
2. Expression of Amylase, Mist1, and PSP mRNAs in primary rat parotid gland 
cells in test media ...................................................................... 18 
3. Basal expression of Amylase, Mist1, Tcf12, and PSP mRNAs in ParC5 cells 
compared to parotid tissue cells, normalized against GAPDH ............. 21 
4. Average Expression of Amylase, Mist1, and PSP mRNAs in ParC5 cell 
cultures .................................................................................... 23 
5. Expression of Amylase, Mist1, and PSP mRNAs in individual ParC5 cell 
cultures .................................................................................... 25 
6. Schematic of CpG island located -1250 bp upstream from Mist1 's transcription 
start site ................................................................................... 42 
7. Illustration of location of CpG sites located around transcriptional start site of 
the Parotid Secretory Protein gene ................................................ .44 
8. Example of verification of size of PCR products ............................ .46 
vi 
LIST OF TABLES 
TABLE PAGE 
1. Methylation status of the 23 CpG sites in the CpG island located in the adult 
rat Mist1 gene's promoter region ......................................................... .49 
2. Methylation status of the 7 CpG sites surrounding the transcriptional start site 
in the adult rat parotid secretory protein gene ......................................... 50 
3. Comparing methylation status of CpG sites for Mist1 in adult rat gland samples 
to status at 0 h time point.. .................................................................. 52 
4. Comparing methylation status of CpG sites for PSP in adult rat gland samples 
to status at 0 h time pOint.. .................................................................. 53 
5. Comparing methylation status of CpG sites for Mist1 in adult rat in culture at 0 
hand 18 h time points ....................................................................... 55 
6. Comparing methylation status of CpG sites for PSP in adult rat in culture at 0 h 
and 18 h time points .......................................................................... 56 
vii 
CHAPTER I 
INTRODUCTION- PART I 
Serum Growth Factors Do Not Prevent De-Differentiation of Salivary Acinar 
Cells 
Human saliva is produced by three pairs of major salivary glands, and a 
variety of minor salivary glands. The major glands are the parotid glands, the 
submandibular glands, and the sublingual glands. Each set of major glands are 
located bilaterally: the largest set of glands, the parotids, are a somewhat 
inverted pyramid shape, located anterior and inferior to the ear, wrapping around 
the posterior border of the mandible; the submandibular glands are roughly egg-
shaped, approximately half the size of the parotid glands, and located in the 
submandibular fossa on the medial surface of the body of the mandible, inferior 
to the mylohyoid line; and the smallest pair, the sublingual glands, are almond 
shaped, resting just beneath the mucous membrane in the floor of the mouth 
between the genioglossus muscle and the body of the mandible [1]. The minor 
salivary glands are found in many locations in the mouth, including in the tongue, 
lips, buccal mucosa, and throughout the palate. 
The three pairs of major glands produce the vast majority of saliva, as was 
demonstrated by Hand in 1986, who found that 60-70% of saliva comes from the 
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submandibular glands, 25-35% from the parotid glands, and 5-8% from the 
sublingual glands [2]. All of these glands are exocrine in nature, secreting their 
respective serous fluid or mucous from clusters of cells known as acini into ducts. 
Each gland also has a major duct by way of which the saliva enters the mouth: 
the parotid empties into the oral cavity through Stensen's duct, which opens 
between the cheek and the maxillary second molar. The submandibular gland 
empties through Wharton's duct, which has a small opening near the lingual 
frenum at the sublingual caruncle. The sublingual gland has smaller ducts, 
known as the ducts of Rivinus, some of which join the submandibular duct, some 
of which open directly into the mouth. There is also a larger sublingual duct, 
known as the duct of Bartholin, which also joins Wharton's duct to exit at the 
sublingual caruncle. 
The saliva secreted by each of these major glands differs in makeup. 
Over 1,100 proteins have been identified in salivary gland secretions, some of 
which are being tested for diagnostic value [3]. Parotid acinar cells secrete a 
wide variety of proteins with varied functions, including amylase, histatins, and 
parotid secretory protein (PSP) [3]. The parotid glands are almost completely 
serous (proteinaceous) in nature, whereas the other major glands, the 
submandibular and sublingual glands, are considered mixed glands, because 
they contain mucous acini capped with serous demilunes, allowing them to 
secrete both serous fluid as well as mucous. The submandibular gland produces 
significant amounts of both fluids, although the majority is serous, whereas the 
sublingual gland is predominantly a mucous secreting gland [4, 5]. 
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The functions of saliva and its contents are extensive and clinically 
important. The most obvious role saliva plays is to moisten food and aid in 
swallowing, but it also functions in protection of the hard and soft tissues, 
digestion of carbohydrates, development and function of taste buds, and 
immunity against bacteria and fungus. As reported by Mandel in 1987, saliva 
lubricates the hard and soft tissue of the oral cavity, allowing food to pass into the 
esophagus smoothly. The frequent lavage of saliva also helps prevent food from 
being trapped between teeth. Enamel, when hydrated, is the strongest material 
in the body, but when desiccated (as happens when there is no saliva), it 
becomes brittle. Brittle teeth are much more prone to fractures and there is a 
greatly increased vulnerability to dental caries. Not only are dry teeth more 
susceptible to decay, but they allow a faster buildup of plaque and calculus, as a 
constant flow of saliva helps minimize accumulation of bacteria on teeth. This is 
due not only to the physical state of the teeth being more lubricated and more 
difficult for bacteria to adhere, but also because saliva itself has anti-bacterial 
and anti-fungal characteristics thereby reducing the number of colonies forming 
on a well lubricated tooth [6]. Another contributing factor of saliva's protection 
against bacteria is the pH buffering system present. As bacteria metabolize 
sugars, acids are produced that begin to destroy tooth structure. However, 
buffering components, like bicarbonate and phosphate, in saliva help raise the 
pH to minimize harm to the teeth by the acid [7]. Other minerals found in saliva 
help re-mineralize the teeth if any demineralization has taken place, or in post-
eruption maturation of teeth [6]. The moisture provided by saliva also 
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significantly influences one's perception of taste. Taste buds have 
chemoreceptors that are stimulated by the chemical makeup of the food 
consumed. As the saliva present in one's mouth moistens food, chemicals in the 
food are solubilized, allowing the taste buds to detect the flavor [8]. 
Salivary glands are the focus of this research because there are 
numerous pathological conditions where functions of the salivary glands are lost. 
Sjogren's syndrome (OMIM 270150) is a condition that results in the partial to 
complete loss of salivary gland function [9-11] and it occurs in primary and 
secondary forms. The primary form of Sjogren's syndrome is an autoimmune 
reaction involving a lymphocytic infiltration of the major and minor salivary 
glands, which results in a decrease in salivary flow and often atrophy of the gland 
itself [12, 13]. Secondary Sjogren's syndrome is sequelae to another pre-existing 
condition, which is usually rheumatoid arthritis or another autoimmune 
connective tissue disease [12]. In about one-third of Sjogren's sufferers, there is 
an enlargement of the parotid or submandibular glands known as benign 
Iymphoepithelial lesion, or Mukulicz's disease. Although the gland hypertrophies 
as opposed to atrophies, there is still an irreversible decline in function of the 
gland and resultant decrease in salivary production [12, 14]. 
Head and neck radiation used in the treatment of cancer patients is also a 
common cause of the destruction of the salivary glands [14]. According to 
Cooper, et 81. [15], "irradiated mucocutaneous tissues demonstrate increased 
vascular permeability that leads to fibrin deposition, subsequent collagen 
formation, and eventual fibrosis. Irradiated salivary tissue degenerates after 
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relatively small doses, leading to markedly diminished salivary output." In 
addition, tumors of the parotid gland require partial to total excision of the gland 
due to the high probability of recurrence [16]. 
Parotid agenesis has also been seen alone and in addition to a variety of 
congenital conditions including: hemifacial microstomia, mandibulofacial 
dysostosis (Treacher-Collins syndrome), cleft palate, lacrimo-auriculo-dento-
digital (LADD) syndrome, anophthalmia, ectodermal dysplasia, whereas 
hypoplasia of the parotid gland has been associated with Melkersson-Rosenthal 
syndrome [9]. 
Although there is a wide range in the etiologies behind the loss of salivary 
function, the oral complications are similar throughout, and they cause a variety 
of problems including: extreme xerostomia; extensive dental caries (especially in 
the cervical and cusp tip areas of teeth); rampant fungal infections; altered taste 
sensations; trouble speaking; sensitivity to acids; difficulty eating dry foods; 
erosion and ulceration of inflamed mucosa; sensitivity to spicy foods; fissured 
erythematous tongue; dsyphagia; cracked, peeling, or atrophic lips; corrugated 
and discolored buccal mucosa; loss of papillation on the tongue; difficulty 
wearing dentures and oral prostheses; and an overall vast decrease in the quality 
of life [9, 14, 17-21]. A common result of the dry oral cavity is the increase in 
number and proportion of Streptococci mutans and lactobacilli, the main bacteria 
responsible for dental decay [9, 21]. An increase in Candida albicans with 
resulting chronic erythematous oral candidiasis has been reported in about one-
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third of Sjogren's patients [22]. This frequent candidiasis has been linked to a 
common complaint of angular cheilitis [20] and problems with dentures. 
According to the Sjogren's syndrome Foundation, an estimated four 
million people in the United States suffer from Sjogren's alone, 85-90% of whom 
are females, with a mean age of 50 [20]. Along with radiation therapy being a 
common treatment for cancers found in the head and neck, and patients who 
have congenital problems or loss of the gland due to excision, the population 
affected by lack of salivary gland function is far from small and deserves the 
attention and efforts of the medical, dental, and research fields. 
A focus of this laboratory is to effectively study these cells, so that 
progress can be made towards helping this patient pool. However, we must first 
be able to maintain parotid cells in culture. Unfortunately, we find that they lose 
cell-specific function, or de-differentiate, within twenty-four hours, rendering them 
useless [23]. As the body develops, cells that are less specialized become 
increasingly more specialized, or differentiate, to become cells with specific 
functions such as liver, brain, skin, glandular cells, etc. When a cell de-
differentiates, as we see with parotid cells placed in culture, the cells no longer 
behave like parotid cells, although they do not die. This can be observed by 
measuring expression levels of mRNAs that serve as markers of differentiation, 
i.e., mRNAs that are only present in a specific cell type, such as a seromucous 
parotid acinar cell. 
A stem cell is a cell that is able to differentiate into any type of cell, and 
much of today's research investigates the use of stem cells to replace missing or 
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damaged tissue. In a promising study in 2008, Lombaert showed that 
implantation of salivary stem cells into submandibular glands of mice that had 
been irradiated, allowed the stem cells to differentiate into acinar and ductal cells 
to restore the destroyed glands [24]. If it were possible to perform similar 
procedures in parotid glands in human patients, this large patient population 
could be treated successfully. As previously mentioned, parotid cells have 
proven extremely difficult to study for any prolonged amount of time, which limits 
the ability to develop procedures such as Lombaert used on submandibular cells. 
Quissell reported in 1994, "Nontransformed adult rat salivary acinar cells 
cannot be sustained in vitro without an extracellular matrix substrate and they will 
not survive on plastic [25]." As mentioned previously, a way to verify that parotid 
acinar cells are not maintaining a differentiated state in culture is to measure 
expression of cell-specific mRNAs as markers of differentiation. For this 
purpose, I have used the mRNAs for three different genes; Mist1, PSP, and 
amylase. Mist1 is a transcription factor expressed only in serous and 
seromucous cells of exocrine glands, which is required for complete 
differentiation of those glandular cells. Pin reported in 2000, that not only do all 
serous-secreting exocrine cells typically express high levels of Mist1, but also all 
other cell types are Mist1-negative. Thus, Mist1 represents the first transcription 
factor that is unique to serous-secreting cells, suggesting that Mist1 may be 
involved in the differentiation of seromucous cells [26]. 
Parotid Secretory Protein (PSP) is another marker of differentiation. PSP 
is known to have antibacterial properties, and was shown by Shaw in 1986 to be 
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the most abundant gene product in the mouse parotid gland. After analyzing 11 
different tissue types, Shaw concluded that the parotid secretory protein gene is 
expressed exclusively in the parotid gland [27]. 
The acinar cells of the pancreas and the salivary glands, especially the 
parotid gland, produce amylase. Salivary amylase is required for the initial step of 
chemical breakdown of carbohydrates for digestion, whereas pancreatic amylase 
continues the same process after food has passed through the upper portion of 
the alimentary canal. Meisler and Ting, in 1993, demonstrated that pancreatic 
and salivary amylase are almost identical in structure, except for a 1 kb fragment 
in the 5' promoter region of the gene, which is sufficient to function as an marker 
of cell-specific expression [28, 29]. Therefore, Mist1, amylase, and PSP are 
markers of terminal differentiation of parotid acinar cells. Importantly, the rapid 
loss of the mRNAs for these markers of differentiation provides a quantitative 
measure for changes in the differentiation status of the cells. 
In an attempt to establish a medium that would maintain a differentiated 
state, we have cultured primary rat parotid cells in various media supplemented 
with species-specific growth factors, proteins, and steroids. These supplements 
included: rat serum (or calf serum, depending on the trial), epithelial growth factor 
(EGF), cystatin, retinoic acid (RA), triiodothyronine (T3), hydrocortisone, trace 
element mixtures, fibroblast growth factor (FGF), insulin, transferrin, and 
selenium. 
We also tested the different growth conditions with a rat parotid cell line, 
known as Pare5 cells. As Bockman noted in 2001, "one important obstacle to a 
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better understanding of ... salivary gland secretion has been the lack of an 
immortalized cell line maintaining the phenotypical characteristics of an epithelial 
cell of acinar origin" [30]. However, in 1998, Quissell et al. and Turner et a/., 
reported the immortalization of clonal rat parotid gland acinar cell lines (parC5 
and ParC1 0) that manifest similar characteristics as those seen in native parotid 
acinar cells on morphological, biochemical, and functional levels [30, 31, 32]. 
These cells were transformed with simian virus 40, allowing them to persist in 
vitro indefinitely without much loss of differentiation over time or over the course 
of multiple passages [31]. The ParC5 line was used for this experiment, as 
Quissell considers it to be the most highly differentiated cell line. Since this is a 
well-characterized parotid acinar cell line, we used modern molecular tools to 
define whether these cells maintain a differentiated state. 
The objective to establish a medium that will maintain primary rat parotid 
acinar cells in a differentiated state was focused to examine the efficacy of the 
supplements in preventing the loss of expression of the markers of differentiation, 
Mist1, amylase, and PSP, in primary adult rat parotid acinar cells. The study also 
looked at the efficacy of the supplements in inducing expression of these 
markers of differentiation in the immortalized parotid cell line, ParC5. We 
hypothesized that growth factors will prevent the de-differentiation of primary 
cultures of parotid salivary gland cells, and they will induce differentiation of 
ParC5 cells. This is a robust approach since two models systems (primary cells 




MATERIALS AND METHODS~ PART I 
Harvest and purification of primary rat parotid glands 
Adult rats were euthanized with CO2 according to approved methods of 
UofL IACUC (IACUC Approval # 08050). Parotid glands were collected from 
Sprague-Dawley rats (Harlan, In.) and minced finely. The parotid tissue was 
suspended in Hank's Buffered Salt Solution (HBSS; Biowhittaker)+0.5% BSA 
with oxygen bubbled through the solution constantly. The cell solution was 
centrifuged at 700 rpm for 1 minute, and the pellet was collected. The pellet was 
re-suspended in 10 ml of HBSS+0.5% BSA. Cells were then digested with 2.5 
units of Collagenase A and 2 mg Hyaluronidase (Worthington Biochemical Co., 
N.J.) for 2 h at 37°C under oxygen. The solution was filtered though a 70-micron 
cell filter (B.D. Falcon), and the filtrate was layered onto 5 ml of HBSS+4% BSA. 
The solution was then centrifuged again at 700 rpm for 2 min. The cell pellet was 
re-suspended in 10 ml of HBSS+0.5% BSA and centrifuged at 700 rpm for 1 min .. 
The pellet was then collected and washed twice with Waymouth's medium 
(Cambrex, MD) without serum. After the second wash, the cell pellet was 
collected and re-suspended in Waymouth's medium with 10% rat serum 
(Equitech Bio. Inc, TX). The cells were then plated on plastic for 2 h to allow 
fibroblasts to attach to the plate. The non-adherent cells are primarily acinar 
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cells, and were collected by centrifugation, re-suspended in the various test 
media (the independent variables), and plated on collagen-I coated plates (BO 
Biosciences). The cells were cultured at 37°C with 5% CO2 . 
Culture media and conditions 
After reviewing multiple journal articles involving prolonged cultures of 
primary rat parotid cells, various supplements that the authors considered 
essential to the success of their cultures were selected for this project's media 
[17,21,22]. The four different types of media used are as follows: 
Standard Control Media (SCM): Waymouth's solution with L-Glutamine, Penicillin 
(100 U/ml), Streptomycin (0.1 mg/ml) (Invitrogen), ITS-X Supplement (1 OOX) 
(Gibco), 10% Rat Serum, and Hydrocortisone (1 ~M) (Sigma). A set of trials was 
done comparing bovine and rat serum, which used 10% fetal calf serum (Atlanta 
Biologicals) in this medium. 
Rat Serum Medium (RSM): Waymouth's solution with L-Glutamine, Penicillin 
(100 U/ml), Streptomycin (0.1 mg/ml), ITS-X Supplement (1 OOX), 10% Rat 
Serum, Hydrocortisone (1 ~M), T 3 (10 nM), and EGF (10 ng/ml) (Invitrogen). 
Cystatin/Rat Serum Medium (CRS): Waymouth's solution with L-Glutamine, 
Penicillin (100 U/ml), Streptomycin (0.1 mg/ml), ITS-X Supplement (1 OOX), 10% 
Rat Serum, Hydrocortisone (1 ~M), and cystatin (10 nM). 
RA/FGFlTrace Element Medium (RFT): Waymouth's solution with L-Glutamine, 
Penicillin (100 U/ml), Streptomycin (0.1 mg/ml), ITS-X Supplement (1 OOX), 10% 
Rat Serum, Hydrocortisone (1 ~M), T3 (10 nM), EGF (10 ng/ml), cystatin (10 nM), 
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retinoic acid (0.1 )lM) (Sigma), Fibroblast Growth Factor (100 ng/ml), and Trace 
Element Mixture (ICN Biomedicals). 
Plated primary parotid acinar cells were incubated at 37 DC with 5% CO2 
for twenty-four hours. 
Collection of cells 
Parotid acinar cells were collected from each culture and centrifuged (3 
min at 3000 rpm) at 0 hand 24 h time points. The wells were washed with 
autoclaved PBS, and that solution was collected and centrifuged as well. Finally, 
the wells were washed with Trizol and mercaptoethanol. This solution was 
collected and added to the pellets from the previous steps. This approach was 
necessary because the cells are not adherent (at 0 h) or weakly adherent. 
Samples were stored at -80 DC when not being used. 
RNA extraction and analysis of expression levels 
The RNA was then extracted from the cells using the RNA Extraction with 
RNAprotect Cell Minikit from Promega. The RNA was quantified using a 
Nanodrop (Thermo Scientific), qualified using an Agilent bioanalyzer 2100 and 
the Agilent RNA 6000 Nano Marker, and used to prepare cDNA. Reverse 
transcription was performed for 60 min at 42 C using oligo dT(15) (Roche 
Diagnostics, IN). The reaction was stopped by heat inactivation for 5 min at 99 
C. Using specific primers and ABI TaqMan probes for GAPDH, Mist1, amylase, 
TCF12, and PSP, the level of their mRNA in culture was quantified by real-time 
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TaqMan RT-PCR on an ABI 7900 System (Applied Biosystems, CA). The fold 
decrease in expression of the mRNAs was calculated after normalizing to the 
endogenous control (GAPDH). 
PareS cell cultures 
The same methods were used for trials with rat parotid ParC5 cells, 
except the cells were incubated in different media at 37 DC with 5% CO2 for 1 
week before RNA isolation, and the Standard Control Medium was a standard 
ParC5 medium. 
Statistical analyses 
Three independent trials were done for both primary rat parotid acinar 
cells, and ParC5 cells, with each trial plated in duplicate. Differences in the 
expression levels of the markers of differentiation were determined by ANOVA 




Historically, primary parotid acinar cells have proven exceptionally difficult 
to culture for any prolonged period of time, due to the loss of cell specific 
function. This inability to maintain parotid cells that behave like parotid cells 
seriously limits the extent to which they can be studied, and it poses a significant 
problem to investigators of this gland. We have found that within the first twenty-
four hours, the expression of mRNAs for proteins that function as markers of 
differentiation, Mist1, salivary amylase, and PSP quickly decrease to a level that 
is almost undetectable. This exponential decrease is demonstrated in Figure 1, 
and it shows that within one day of culture, the cells are no longer behaving like 
parotid acinar cells, rendering them useless for study. 
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Figure 1. The expression of mRNAs for Mist1, PSP and Amylase are 
significantly and rapidly lowered during the first twenty-four hours of culture. The 
control mRNA for GAPDH and 18S RNA did not change in these experiments. 
This provides a quantitative measure of de-differentiation of acinar cells. 
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This de-differentiation within twenty-four hours creates the questions of, 
why does this happen? And, how can we prevent it? It was hypothesized that 
the de-differentiation is due to a lack of proper growth factors and hormones in 
the culture media, and that the addition of those supplements would prevent the 
de-differentiation of primary parotid acinar cells. This background allows a 
straightforward experimental design by comparing the expression of these 
markers at 0 h and after 24 h culture in various media. 
For the primary parotid acinar cells, after twenty-four hours of culture in 
the different test media, expression levels of the mRNAs for the markers of 
terminal differentiation, Mist1, amylase, and PSP were measured and normalized 
against expression levels of the endogenous control, glyceraldehyde 3-
phosphate dehydrogenase (GAPDH). GAPDH was used as an internal control, 
as it is not a marker of differentiation. This is because GAPDH is present in 
every cell in the body, and its expression is not decreased as the parotid cells de-
differentiate. 
In three independent experiments, three different combinations of 
reagents were tested. When testing primary parotid acinar cells, two replicates 
were completed in each experiment. The reagents included rat serum (or calf 
serum, depending on the trial), epithelial growth factor (EGF), cystatin, retinoic 
acid (RA), triiodothyronine (T 3), hydrocortisone, trace element mixtures, fibroblast 
growth factor (FGF), insulin, transferrin, and selenium. The different 
combinations of the reagents are described in the Methods section. Regardless 
of the media tested, no significant differences were observed between the media 
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for any of the markers of differentiation. Every trial for each marker once again 
resulted in an exponential decrease in expression over the first 24 hours in 
culture (Figure 2). As had been demonstrated previously (Figure 1), compared 
to the initial cells (0 h), there is a dramatic and significant (p<0.05) decrease in 
the total Amylase, Mist1, and PSP mRNA content of parotid cells cultured for 24 
h. 
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Figure 2. Expression of Amylase, Mist1, and PSP mRNAs in primary rat parotid 
gland cells cultured in test media 
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Figure 2. In this experiment, there is a dramatic and significant (*p<O.05) 
decrease in the total Amylase, Mist1 , and PSP mRNA content of parotid cells in 
culture for 24 h. Each bar represents RT -PCR results from cells grown in a single 
well except for the SCM, which is an average of two control wells at 0 hr. Media 
are labeled as: Standard Control Media (SCM), Rat Serum Medium (RSM), 
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Cystatin/Rat Serum Medium (eRS), and RAlFGFlTrace Element Medium (RFT). 
All media consistently showed the exponential decrease, as seen in Figure 1. 
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Due to the continued inability to prevent de-differentiation in trials using 
primary rat parotid acinar cells, we decided to attempt inducing differentiation of 
PareS cells with a hope to increase their expression of markers of differentiation 
to a similar level of that seen in primary cells. It was hypothesized that the 
supplements added to the media would induce further differentiation in the less-
specialized cells of the PareS parotid cell line. Figure 3 depicts the extreme 
differences in levels of expression of the mRNAs for the markers of differentiation 
comparing parotid tissue and the PareS cell line. Since expression of these 
markers of differentiation is so low in Pare5 cells, this provides a very sensitive 
approach to test the effects of the supplements. 
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Figure 3. Expression of Amylase, Mist1 , Tcf12, and PSP in ParC5 cells, 
normalized against GAPDH 
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Figure 3. The expression of mRNAs for amylase, Mist1, PSP, and Tcf12 in rat 
parotid tissue was exponentially higher than seen in ParC5 cells. As a control, 
Tcf12, which is not a marker of differentiation, showed no change. These data 
show that the rat parotid cell line ParC5 have de-differentiated, but not 
completely. To reestablish levels of expression seen in parotid tissue, a 
remarkable increase of ParC5 expression would be required. 
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As mentioned in Chapter II, ParC5 cells were cultured in various media for 
1 week instead of 24 hours, due to the stability of the cell line. The media used 
in the ParC5 trials followed the same recipes as used in the primary acinar 
cultures, which included: rat serum (or calf serum, depending on the trial), 
epithelial growth factor (EGF), cystatin, retinoic acid (RA), triiodothyronine (T3), 
hydrocortisone, trace element mixtures, fibroblast growth factor (FGF), insulin, 
transferrin, and selenium. The Standard Control Medium is a standard ParC5 
medium. 
ParC5 cells were cultured in different media in three separate 
experiments, each of which was plated in duplicate for the control medium and 
the experimental media. In one additional trial using ParC5 cells, media 
containing rat serum was compared to media containing fetal calf serum. Total 
RNA was isolated for each well as described in Methods. mRNAs for marker 
genes were quantified using TaqMan assays, and normalized against GAPDH. 
Results for ParC5 cells in the various test media failed to demonstrate any major 
induction of differentiation, and there was no significant difference between 
media for all markers of differentiation, as seen in Figure 4. 
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Figure 4. Average Expression of Amylase, Mist1 , and PSP mRNA in ParC5 cell 
cultures 
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Figure 4. Each graph shows the level of expression of a marker gene in cells 
grown in 4 different media. Each bar represents the average of 3 experiments. 
The RT-PCR data are normalized to GAPDH and expressed relative to the 
control medium (SCM). No significant differences were found , p > 0.05 as 
compared to SCM. 
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For each media and each marker gene, expression levels were not 
induced exponentially as hypothesized. This means that there was no change in 
the level of differentiation, and there is no direct regulation of individual genes by 
the supplements in the media. Figure 5 demonstrates that even when each 
individual trial is compared to the others, there is no significant induction of 
expression. When levels of expression in Pare5 cells for each individual 
experiment in each media are compared, the differences are minimal. Despite 
the appearance of some variability, no consistent changes in expression of the 
marker genes were found. Even the outliers are still 10,000 to 100 million fold 
shy of primary cells expression levels, which shows the supplements in the 
media do not directly regulate these genes. 
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Figure 5. Expression of Amylase, Mist1 , and PSP mRNA in individual ParC5 cell 
cultures 
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Figure 5. The bars are the averages of the expression levels for the control 
media (SCM) and each test media treatment (RFT, RSM, and CRS), in each of 
the three experiments, for the indicated genes. All trials were normalized against 
GAPDH. Normal differentiated expression levels would be 106-fold higher, as 
shown in Figure 3. 
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Depending on who conducts the research, there is variation in the 
components of the culture media. Some investigators, such as Humphries and 
Reyland et al., have historically used fetal calf serum to culture parotid cells [33], 
whereas others, such as Yoshigaki et al., have used rat serum [34]. Calf serum 
is sometimes used due to increased amount of growth factors found in the serum 
of young animals as opposed to adults, despite the fact that the cells being 
cultured are from rats. In 1998, Zhu et al. showed that use of rat serum in media 
causes an increased expression of amylase in parotid acinar cell lines [35], but 
expression levels were still significantly low compared to parotid tissue. Zhu's 
study did not investigate if rat serum would increase expression of amylase in 
cultured primary cells. To verify this, and to test the effects of the increased 
growth factors from the calf serum, another experiment with ParC5 cells was 
done comparing the test media to another set of identical test media, except that 
it contained 10% calf serum instead of the 10% rat serum in the original recipes. 
As done in the previous ParC5 trials, all samples and controls were plated in 
duplicate and allowed to grow for 1 week. Control media was the same standard 
ParC5 media used in previous trials. RNA was isolated and subsequently used 
to make cDNA for RT-PCR for Amylase and PSP mRNAs, normalized against 
GAPDH. Contrary to Zhu's findings, no significant differences in the levels of 
expression of markers of differentiation were noted between the samples 
cultured in calf serum media compared to those cultured in the rat serum media. 
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CHAPTER IV 
DISCUSSION· PART I 
Due to the large patient population that suffers from salivary gland 
problems such as Sjogren's syndrome, there is a definite need for parotid glands 
to be studied. However, when placed in culture, parotid acinar cells de-
differentiate so that within twenty-four hours they lack the cell-specific 
characteristics that identify them as parotid cells. This de-differentiation makes 
studying these cells extremely difficult, and it creates a problem for investigators 
that needs to be solved. Using primary cells in culture is an excellent model, but 
only if the cells maintain their natural identity, which makes understanding the 
differentiation, and de-differentiation, process of these cells important. 
Parotid acinar cells show a significant and dramatic decline in the 
expression of markers of differentiation such as Mist1 , amylase, and PSP within 
6 h of cell culture, and by the 24 hour time point, these markers are almost 
undetectable (Figure 1). Because of this loss of expression, there is no good 
model for the study of differentiated acinar cells. There are various hypotheses 
about why primary parotid acinar cells de-differentiate in culture, including the 
lack of growth factors in vitro that are normally present in vivo, and it was our 
goal to determine if these factors regulated the genes for markers of 
differentiation. This study strongly argues against this hypothesis, as all data 
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showed no decrease in severity, or rate, of de-differentiation of the parotid cells 
once placed in culture, despite different combinations of eleven growth factors 
and hormones. These reagents had been used in various publications that 
claimed to have differentiated cultures of acinar cells, however they did not 
directly compare cultured cells to parotid gland cells [35, 34, 33]. The reagents 
included: rat serum (or calf serum), epithelial growth factor (EGF), cystatin, 
retinoic acid (RA), triiodothyronine (T3), hydrocortisone, trace element mixtures, 
fibroblast growth factor (FGF), insulin, transferrin, and selenium. No significant 
change in expression of markers of differentiation was noted throughout the 
study, and none of the factors prevented the de-differentiation of acinar cells in 
culture. 
Since there was no prevention of de-differentiation of the primary rat cells, 
we made an attempt to induce differentiation in the stable parotid cell line, ParC5 
cells. Although these cells maintain some characteristics of acinar cells, the 
levels of expression of the markers of differentiation are stable, but exponentially 
lower than those seen in parotid tissue. The goal was to increase the levels of 
expression towards that of the acinar cells by culturing the ParC5 cells in a 
medium that contained the growth factors present in the body. Depending on the 
marker of differentiation, the level of increase needed to mimic that of primary 
cells ranged from 10,000 fold to 100 million fold, as can be seen in Figure 3. 
After culturing the cells for a week in the enriched media, compared to the 
control medium, the average increase in expression was 1.031 fold for amylase, 
1.529 fold for Mist1, and 1.299 fold for PSP. Obviously this is not the exponential 
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rise in expression that was needed to be comparable to differentiated acinar 
cells, which argues that these growth factors and hormones can not induce 
differentiation in parotid gland cell lines such as Pare5 cells. 
Also, we found that some investigators have chosen to use fetal calf 
serum [33] instead of rat serum [35] to culture parotid cell lines. Zhu et al. 
reported in 1998 that there was an induced increase in expression of amylase 
when using rat serum compared to that of fetal bovine serum. During this study 
of Pare5 cells comparing identical culture conditions, except for the variable of 
calf serum or rat serum, there was no significant difference in levels of 
expression for any markers, including amylase. 
Within the limits of this experimental design, these findings indicate that a 
lack of growth factors is not the causative issue behind the loss of differentiation 
of primary parotid acinar cells. This study also shows that growth factors do not 
induce differentiation of parotid cell lines, such as Pare5. Therefore, alternative 
mechanisms to explain this loss of cell specific function must be explored with 
further investigation. The following chapters of this thesis address the possibility 
that epigenetic changes influence the differentiation of parotid gland acinar cells. 
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CHAPTER V 
INTRODUCTION - PART II 
DNA Methylation of Marker Genes During De-differentiation of Parotid Cells 
Genetic information is contained in the linear strands of DNA in each cell, 
and encoded in this information are mechanisms that determine which genes will 
be expressed. However, there are factors other than just the DNA itself that 
regulate gene expression, such as epigenetic mechanisms [36]. Epigenetics, by 
definition, is "above or beyond the genome," which includes mechanisms that 
"establish heritable states of gene expression without altering the DNA 
sequence" [36, 37]. There are various epigenetic processes including post-
translational modification of histones, generally including acetylation, 
phosphorylation, and/or ubiquitinylation. Histones are proteins found in 
eukaryotic cell nuclei that help package the DNA into units known as 
nucleosomes [38, 39]. DNA is wrapped around the histones, similar to thread on 
a spool, which allows the very long (1.8 meters) strand of DNA to be condensed 
down to about 90 millimeters on the histone [40]. This strand of DNA, wrapped 
around many histones, is often referred to as a string of pearls. This combination 
of nucleosomes and DNA, plus additional structural proteins, is known as 
chromatin. The chromatin then condenses further to form chromosomes, 
allowing for the 1.8 meters of DNA to be about 120 micrometers of chromosomes 
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[40]. When histones are modified by acetylation, phosphorylation, and/or 
ubiquitinylation, it can change the way the DNA is wrapped around them; thereby 
changing what DNA is accessible to complexes like DNA polymerases. DNA 
polymerases are enzymes that function to replicate and transcribe the contents 
of a DNA strand [41]. This explains why these epigenetic modifications of 
histones interact to alter chromatin structure and function, which subsequently 
alters expression [36], and why the modifications can be passed on through 
replication to subsequent generations without modifying the DNA sequence itself. 
A second class of epigenetic regulation involves modification of the DNA 
itself. According to Bird in 2002, the most studied epigenetic modification in 
mammals is not histone modifications, but DNA methylation [42]. DNA 
methylation is thought to play many roles in cell physiology, "including genome 
stability, repression of endogenous retroviral and transposable elements, 
genomic imprinting, and developmental gene regulation" [42-47]. 
Interestingly, DNA methylation can only occur at one specific base pair, 
which is the 5' site of a cytosine that immediately precedes a guanine. This 
cytosine-guanine dinucleotide is referred to as a CpG site, and the enzyme DNA 
methyltransferase, using S-adenosyl methionine as the methyl group donor, is 
responsible for the conversion of cytosine to 5' methylcytosine [36]. Once the 
DNA is methylated, the methyl group protrudes into the major groove of the DNA 
subsequently displacing transcription factors that ordinarily bind to the DNA [36, 
48]. Also, the sites that have been methylated can attract methyl-binding 
proteins, known as methyl-CpG-binding domain proteins (MBDs), which are 
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involved in 'reading' methylation marks [49]. These MBDs then recruit histone 
deacteylases that modify the tails of the histone proteins, resulting in chromatin 
condensation [36, 47]. Once chromatin has been compacted, there is often the 
result of gene silencing [34]. 
CpG sites occur throughout the genome, but there are areas that include 
much higher concentrations of these sites, known as "CpG islands." These are 
variably defined, but generally have a region of 200 base pairs with at least 50% 
G or C content. CpG islands often encompass promoter regions and 
transcriptional start sites of the associated gene, and they have been shown to 
be present in the promoter region of 50-70% of human genes [50, 51]. As the 
many possible sites in CpG islands undergo methylation, it becomes increasingly 
difficult for the transcription factors to bind, and more and more MBDs are 
attracted and recruit transcriptional repressors [52-54]. Due to these 
mechanisms, there is a well-established relationship between methylation of the 
promoter region and transcriptional repression [55, 52, 56, 57]. Also, according 
to Jones and Laird in 1999, not only mayan increase in methylation in promoter 
regions lead to decreased expression, but a decrease in promoter region 
methylation may possess the potential for up-regulating gene expression [58]. 
This re-affirms that there is a clear link between epigenetic modifications and 
regulation of gene expression. 
Not only can DNA methylation affect gene expression, but also there is 
evidence to support that it may play roles in the differentiation of cells [50]. In 
1979, Taylor and Jones showed that by inhibiting DNA methylation in fibroblasts, 
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the cells can transform into muscle cells and other types of differentiated cells, 
which suggests that gene methylation regulates the process of differentiation [50, 
59]. Considering this fact, and the difficulty in maintaining a differentiated state of 
primary rat parotid acinar cells when placed in culture (described in Part I, 
above), the second part of my study was directed at trying to determine if DNA 
methylation is causing a loss in differentiation of these cells. If promoter regions 
of the genes that serve as markers of terminal differentiation are becoming 
methylated during culture, it may cause a repression in gene expression and 
therefore a loss of differentiation. 
The first step of my epigenetics research was designed to establish the 
presence of CpG sites and islands located in the promoter regions of the genes 
that encode terminal markers of differentiation such as Mist1 and PSP in adult 
rats. The next stage was to determine the level of methylation of these CpG 
sites. This study also examined the methylation status of the known CpG sites 
after the cells had been placed in culture for ° hand 18 h time points so as to 
evaluate if there was a change in the level of methylation over time. 
In order to identify whether or not a CpG site has been methylated, 
bisulfite conversion is a very useful procedure. When treated chemically with 
bisulfite, any cytosine that is not methylated will be converted to uracil [60, 61]. 
Unmethylated cytosines are chemically converted to uracils, which are amplified 
as thymidine by the PCR step. Thus, if DNA is treated with bisulfite, amplified 
with PCR, and analyzed by sequencing, any remaining cytosines indicate a CpG 
site that had been methylated. By first testing the level of methylation of adult rat 
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parotid cells immediately after harvest, a baseline will be established so that 
changes in methylation during culture can be recognized. 
The main objective of this part of the study is to establish if DNA 
methylation prevents transcription of terminal markers of differentiation in primary 
rat parotid cells in culture. I hypothesized that global methylation of the genes 




MATERIALS AND METHODS· PART II 
Identification of CpG Islands 
The first step of this part of the study required identifying the presence, 
number, and location of CpG islands in the promoter regions of the desired 
genes, Mist1 and parotid secretory protein (PSP). Using the National Center for 
Biotechnology Information's (NCBI) rat genome database 
(http://www.ncbi.nlm.nih.gov/guide/rat), the transcriptional start site in the DNA 
sequence for each desired gene was located. A 4,000-nucleotide section of DNA 
sequence was copied spanning from 2,000 nucleotides upstream of the 
transcriptional start site to 2,000 nucleotides downstream. This ensured that if a 
CpG island located in the promoter region continued somewhat past the start 
site, it would still be completely contained within the section of DNA sequence. 
Using the European Bioinformatics Institute's EMBOSS 
(http://www.ebi.ac.uklTools/emboss/cpgploU). the 4,000-nucleotide sections of 
DNA were analyzed for the presence of CpG islands. Conveniently, PSP lacked 
any CpG islands in its promoter region, allowing it to act as a negative control. 
Polymerase Chain Reaction (PCR) primer design 
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Once CpG islands were located, PCR primers were designed so that the 
individual islands could be amplified for analysis. Mist1 had a 387 base-pair CpG 
island in its promoter region that primers were designed to amplify. Since PSP 
lacked any CpG islands, PCR primers were designed for a 692 base-pair section 
of DNA that was centered around the transcription start site. The Mist1 gene 
CpG island was amplified using the following primers: a) the sense primer 5'-
TGTTGGTGATGGTAATGTTGGTA and b) the anti-sense primer 5'-
CCAATCAAACTCAAAAACATCAA. The primers for the PSP gene DNA were as 
follows: a) the sense primer 5'-TGAGTTTTTAAAAGATGATTGGGTTA and b) the 
anti-sense primer 5'-CCCACTATCTATCTCCACCAAAC. 
Harvest and purification of rat parotid glands 
Parotid glands were collected from adult rats and minced finely, as 
described in Chapter II. The parotid tissue was suspended in Hank's Buffered 
Salt Solution (HBSS) + 0.5% BSA with oxygen bubbled through the solution 
constantly. 
At this point, there were two different paths taken, depending on the goal 
of the experiment. In order to evaluate the level of methylation present in parotid 
cells before any time in culture, 20 III of proteinase K (600 mAU/ml) was added, 
vortexed, and then placed in a 56°C water-bath for overnight lysis in preparation 
for DNA isolation. 
The other route was to determine the amount of change in methylation 
during culture, comparing a 0 hand 18 h time point. For the cells used in this 
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type of experiment, cells were placed in Waymouth's medium, pelleted, digested 
with hyaluronidase and collagenase, and plated on plastic to allow for attachment 
of fibroblasts, as was described in detail in Chapter II, Materials and Methods. 
As soon as the cells were ready to be plated, the 0 h time point samples were 
harvested, and DNA isolation was initiated. The remaining samples were plated 
in Waymouth's medium + 10% rat serum for 18 h at 37°C before being 
harvested and having DNA isolated. 
The samples that were not prepared for culture, but were taken from the 
tissue and immediately prepared for DNA isolation will be referred to as "gland" 
or "gland samples." The samples that were prepared for culture and were taken 
at specific time points will be referred to at "0 h" and "18 h" samples. 
DNA Isolation 
Adult rat DNA was isolated from the parotid glands following the QIAGEN 
Mini Kit protocols exactly according to the manufacturer's instructions. Nuclease-
free water was used to elute each sample. All DNA isolations were quantified 
using the Nanodrop. 
Bisulfite Conversion 
Using ZYMO Research EZ DNA Methylation-Direct Kit, isolated DNA was 
treated with bisulfite to convert all unmethylated cytosines to uracils. 500 ng of 
DNA was used for each round of bisulfite conversion. 20 III of DNA & CT 
Conversion reagent was used for each column of bisulfite treatment, which was 
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eluted with 15 III of PCR grade water instead of 10 III of M Elution Buffer. Each 
sample of bisulfite converted DNA was quantified using the Nanodrop. Multiple 
(23) bisulfite conversions were completed for this experiment to provide 
independent samples for PCR. 
Amplification of DNA using Polymerase Chain Reaction 
Using between 50-100 ng of DNA, a PCR was run with 45 III of PCR 
Supermix and 2.5 III (1 :20 ratio of primer to PCR grade water) of each primer. 
The PCR was run at 95°C for 10 minutes, then 40 cycles involving 94°C for 30 
seconds, 55°C for 30 seconds, and 72 °c 1 minute 30 seconds, and finally 72°C 
for 10 minutes before moving into a 4 °c infinite holding temperature. PCR 
products were verified to be single bands of the expected size by running 
samples through a 1 % agarose gel. 
Cloning of PCR products into E. coli 
Using the fresh PCR products that were confirmed to be successful, PCR 
fragments were cloned into Topo® vector and One Shot® Top10 competent 
bacteria using the Invitrogen Tapa TA Cloning® Kit for Sequencing. 12-15 III of 
Top10 cells was used per clone, depending on how many PCR products were 
being cloned during the trial. 10-15 III of the Top10 cell solution was used to run 
a negative control that received no DNA or Topo®. Protocols for "Chemically 
competent E. coli" were followed, which calls for 2 III of PCR DNA. Cells were 
transformed using the heat-shock method protocol. Once ready for plating, two 
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sterile Luria Broth + Ampicillin agar plates were used for every clone: 50 ~I of 
clone was spread on one plate, 1 00 ~I of the clone was spread on the other. 100 
~I of the Negative Control was spread on another plate. All plates were incubated 
overnight at 37°C, and remaining bacteria solutions were stored at 4°C. 
The following day, colonies were counted, selected, and harvested using 
sterile pipette tips. Each harvested colony was placed in its own 50 ml centrifuge 
tube with 10 ml of the LB broth and 50 ~I of Ampicillin. The tubes were then 
placed in a shaker at 200 rpm at 37°C overnight to grow the bacteria. 
A master plate was made with each colony selected using 1 ~I of the 
bacteria filled media on a sterile Luria Broth + Ampicillin agar plate, and stored at 
4°C. A total of 112 clones were made from fresh PCR products during this 
experiment. 
Plasmid Isolation from Clones 
After allowing the culture tubes to incubate in the shaker overnight, 
plasmid DNA was isolated following the Promega Wizard Plus SV Mini Prep 
protocols. All isolated DNA samples were characterized and quantified using the 
Nanodrop. Isolated DNA was divided into 10 samples for each Mist1 and PSP 
for the gland samples. However, DNA was isolated and divided into four 
samples for each Mist1 and PSP at both the 0 hand 18 h time points. 
DNA Sequencing 
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In order to identify which CpG sites had been methylated, the isolated 
DNA was sequenced and compared to the known rat genome sequence. To do 
this, 400 ng of isolated DNA from the Promega Mini Preps was added to a 0.2 ml 
PCR tube. The total volume was brought up to 10.4 III using Nuclease Free 
Water. Samples were then taken to the Center for Genetics and Molecular 
Medicine at the University of Louisville for DNA sequencing. Once sequences 
were received, they were compared to each other and to the rat genome from 
NCB I for accuracy and to evaluate which CpG sites were methylated. 
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CHAPTER VII 
RESULTS· PART II 
Before being able to identify changes in methylation over time, we needed 
to define the methylation status of each CpG site in the CpG island in the Mist1 
gene in adult rat. To do this, DNA from harvested parotid glands was 
immediately isolated ("gland samples"), as opposed to being plated in culture for 
any amount of time before DNA isolation (0 hand 18 h time points), as 
mentioned in the Chapter VI, Materials and Methods, Part II. 
Bioinformatic analysis identified a CpG island in the promoter region of 
Mist1, spanning 387 base pairs, and terminating 863 base pairs upstream of the 
transcriptional start site. There are 23 CpG sites within this CpG island, as is 
illustrated in Figure 6. 
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Figure 6. Schematic representation of the CpG island located -1250 bp 
upstream from Mist1 's transcription start site 
863 bp 







CpG Sites Eligible for 
Methylation 
Figure 6. This figure shows the location of the CpG sites, which are eligible for 
methylation, in relation to each other and to the transcriptional start site. The 
methylation status of each site was determined for the gland samples so that it 
could be compared to methylation statuses seen at later time points (0 hand 18 
h) when tissue had been placed in culture media. 
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As previously mentioned, PSP functioned as the negative control, 
because there was no identifiable CpG island present, so a 692 base pair section 
of DNA, centered around the transcription start site, was amplified with PCR. 
While designing PCR primers, a successful set of primers was found that 
encompassed the 692 bp, which was large enough to have a high probability of 
including the majority of CpG sites near the start site, while still being small 
enough that PCR would likely be successful. There are seven CpG sites in the 
692 bp segment, as illustrated in Figure 7. 
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Figure 7. A schematic illustration of the location of the CpG sites located 









Transcription start site 
CpG Sites Eligible for 
Methylation 
Figure 7. No CpG island was identified, so a 692 bp segment centered on the 
transcriptional start site was amplified so that the methylation status of individual 
sites near that start site could be evaluated. 
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To verify that the appropriate size section of DNA had been amplified with 
peR, samples were electrophoresed on 1 % agarose gels. Figure 8 shows an 
example of the resulting gel. 
45 












1 2 3 4 5 
Mist1 
Figure 8. This example is a 1 % agarose gel for PCR products Mist1 and PSP 
run for 40 cycles at 55 DC annealing. Lane 1 contains the DNA ladder for band 
size reference , Lane 2 contains the Mist1 387 bp amplicon , and Lane 5 contains 
the 692 bp PSP product. Samples in lanes 3 and 4 are the correct size ampl icons 
for different genes, not described here. 
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Once the PCR reactions were validated, DNA samples were cloned into 
the Topo®TA plasmid, DNA was purified again, and it was then taken for 
sequencing at The Center for Genetics and Molecular Medicine at the University 
of Louisville. Upon receiving results, the sequences were evaluated to determine 
which CpG sites were methylated. This was done by comparing the returned 
sequences to the rat genome sequence as reported by the National Center for 
Biotechnology Information (NCBI). Any cytosine that remained visible in the 
sequences indicated a CpG site that had been methylated, as any unmethylated 
cytosine remains vulnerable to the bisulfite conversion and would have been 
converted to a uracil. These uracils are amplified as thymidines in the PCR step, 
so every unmethylated cytosine, regardless of being a CpG site or not, will 
appear as thymidine (T) in sequencing. All sequences were compared to the 
genome reported by NCBI to verify the accuracy as well as to ensure that any 
remaining cytOSine did in fact correlate to a CpG site, which are the only sites 
eligible for methyl-protection from bisulfite conversion. Essentially all single 
cytosines in the genomic sequence appeared as T in these cloned sequences, 
demonstrating the high efficiency of the bisulfate reaction. 
Table 1 and 2 illustrate the findings for the Mist1 and PSP genes in the 
gland samples. The methylated (M) or unmethylated (U) status of each CpG 
dinucleotide is shown in the table for each clone (labeled as the name of gene 
being investigated, followed by the sample number). Differences between clones 
are taken to represent the different methylation status of DNA from different cells 
in the sample. Therefore, for the Mist1 island in parotid tissue, while CpG #5 is 
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always unmethylated, CpG #19 is methylated in some cells but not in other cells. 
In general, these results show that this island is highly methylated in vivo in the 
parotid. 
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Adult Rat Gland - Clone # Mist-1 Mist-2 Mist-3 Mist-4 
Mist1 CpG Island CpG # 
1 M M M M 
M = Methylated 2 M M M M 
U = Unmethylated 3 M M M U 
4 M M M M 
M* = C is 5 U U U U 
methylated but G 6 M M M M has a sequencing 
7 M M M M error 
8 M M M M 
9 M M M M 
10 U M M M 
11 M M M M 
12 M M M M 
13 M M M M* 
14 M U M M 
15 M U M M 
16 M U M M 
17 M U M M 
18 M U M M 
19 M U M U 
20 M U M M* 
21 M U M M 
22 M M M M 
23 M M* M M* 
Table 1. Methylation status of the 23 CpG sites in the CpG island located in the 
adult rat Mist1 gene's promoter region. Results show a predominantly 
methylated state throughout the CpG island for the gland samples. 
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Adult Rat Clone # PSP -1 PSP-2 PSP-3 PSP-4 
Gland - PSP 
CpG# Control 
M = Methylated 1 U U U U 
U= 2 U M U U Un methylated 
N/A = 3 U U U U 
Sequencing 4 U M U U 
error covered 5 N/A U N/A U 
area or 6 N/A M N/A N/A 
sequencing 
stopped before 7 N/A M N/A N/A 
this point 
Table 2. Methylation status of the 7 CpG sites surrounding the transcriptional 
start site in the adult rat parotid secretory protein gene. Results show a 
predominantly unmethylated state in the gland, although sequencing terminated 
before completion in some of the samples. 
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As a next step, we compared the results shown in Tables 1 & 2, to the 0 h 
time point results to evaluate if much change occurred in the few hours of 
preparing the cells for culture. There is very little variation between the two sets 
of data for Mist1. However, for the sites sequenced for PSP, there is an over 
three-fold increase in methylation in the 0 h samples compared to the gland 
samples. The 0 h samples did continue closer to completion during sequencing, 
allowing for more chances at methylated sites. Interestingly, CpG site #5 of the 
Mist1 island remains un methylated in all samples, despite the heavy 
concentration of methylated sites throughout the island. This consistency 
strengthens the veracity of the data as it reflects reproducibility in laboratory 
techniques. See Tables 3 & 4. 
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M = Methylated CpG site U = Unmethylated CpG site 
M* = C is methylated but G has a sequencing error 
Gland o h Time Point 
Clone # Mist - 1 Mist - 2 Mist - 3 Mist - 4 Mist - 5 Mist - 6 Mist -7 
CpG # 
1 M M M M M M M 
2 M M M M M M M 
3 M M M U M M M 
4 M M M M M M M 
5 U U U U U U U 
6 M M M M M M M 
7 M M M M M M M 
8 M M M M M M M 
9 M M M M M M M 
10 U M M M M M M 
11 M M M M M M M 
12 M M M M M M M 
13 M M M M* M M M 
14 M U M M M M M 
15 M U M M M M M 
16 M U M M M M M 
17 M U M M M M M 
18 M U M M M M M 
19 M U M U U M M 
20 M U M M* M M M 
21 M U M M M M M 
22 M M M M M M M 
23 M M* M M* M M M 
Table 3. Comparing methylation status of CpG sites for Mist1 in adult rat gland 
samples to methylation status at the 0 h time point. 
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M = Methylated CpG site U ::: Unmethylated CpG site 
N/A = Sequencing error covered area or sequencing stopped before this point 
Gland o h Time Point 
Clone PSP-1 PSP-2 PSP-3 PSP-4 PSP-5 PSP-6 PSP-7 PSP-8 # 
CpG# 
1 U U U U M U M M 
2 U M U U M U M M 
3 U U U U M U M M 
4 U M U U M U M M 
5 N/A U N/A U M U U M 
6 N/A M N/A N/A M U U M 
7 N/A M N/A N/A M U N/A N/A 
Table 4. Comparing methylation status of CpG sites for PSP in adult rat gland 
samples to status at 0 h time point. 
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Finally, 0 hand 18 h time points were compared to determine the amount 
of change in methylation over time in culture, which was hypothesized to 
increase in correlation with the decrease in expression of terminal markers of 
differentiation. As Table 5 shows, there is very little variation between the two 
sets of data for Mist1, but overall a slight decrease in methylation is seen over 
time, contrary to my hypothesis. Once again, the Mist1 CpG site #5 consistently 
remained unmethylated throughout all samples, including the 18 h time point, 
which shows strong data. However in Table 6, which illustrates the PSP findings, 
there is continued increase in methylated CpG sites over the 18 hours, which 
corresponds with my hypothesis that a significant global increase of methylation 
correlates with the simultaneous decrease in expression of PSP mRNA. Results 
for Mist1 and PSP are shown in Tables 5 & 6 respectively. 
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M = Methylated CpG site U = Unmethylated CpG site 
M* = C is methylated but G has a sequencing error 
o h Time Point 18 h Time Point 
Clone # Mist-5 Mist-6 Mist-7 Mist-8 Mist-9 Mist-10 Mist-11 
CpG # 
1 M M M M M M M 
2 M M M M M M M 
3 M M M M U M M 
4 M M M M M M M 
5 U U U U U U U 
6 M M M M U M M 
7 M M M M M M M 
8 M M M M M M M 
9 M M M M M M M 
10 M M M M M M M 
11 M M M M U U M 
12 M M M M* M M M 
13 M M M M M M M 
14 M M M M U M M 
15 M M M M M M M 
16 M M M M U M M 
17 M M M M M M M 
18 M M M M M M M 
19 U M M M M U M 
20 M M M M M M M 
21 M M M M M M M 
22 M M M M M M M 
23 M M M M M M M 
Table 5. Comparing methylation status of CpG sites of the Mist1 gene CpG 
island at 0 hand 18 h time points. 
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M = Methylated CpG site U = Unmethylated CpG site 
N/A = Sequencing error covered area or sequencing stopped before this point 
o h Time Point 18 h Time Point 
Clone # PSP-5 PSP-6 PSP -7 PSP-8 PSP-9 PSP - 10 
CpG# 
1 M U M M M M 
2 M U M M M M 
3 M U M M M U 
4 M U M M M M 
5 M U U M M M 
6 M U U M M M 
7 M U N/A N/A U N/A 
Table 6. Comparing methylation status of CpG sites for PSP in adult rat in 
culture at 0 hand 18 h time points. 
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CHAPTER VIII 
DISCUSSION· PART II 
As demonstrated in Part I, there is an almost complete loss of expression 
of terminal markers of differentiation for parotid acinar cells during the first 
twenty-four hours of being in culture (Figure 1). After confirming that a lack of 
proper growth factors and hormones in the culture media was most likely not the 
cause, a new direction of investigation was followed. ConSidering that 
epigenetics, specifically DNA methylation, has been linked to gene Silencing [55, 
52, 56, 57] and cell differentiation [50, 59] it was hypothesized that an increase in 
methylation in the promoter regions of the markers of differentiation would be 
seen over time in culture, which would correlate with the loss of expression and 
de-differentiation. 
Upon evaluating the methylation status of the CpG sites found in the CpG 
island of Mist1 , the overall trend was one of heavy methylation; very few of the 
total number of sites were in an unmethylated state, as can be seen in Table 1. 
When comparing methylation levels in gland samples to samples at the a h time 
point of culture, there was very little variation in the Mist1 gene (seen in Table 3). 
This was expected, as very little time had elapsed, which would theoretically not 
allow for much methylation to take place. These observations that this CpG 
island is heavily methylated in the Mist1 gene is very important. Heavy 
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methylation of the island under conditions when the Mist1 gene is strongly 
expressed demonstrates that this island is not a site where transcription factors 
must bind to activate the gene. 
When 0 hand 18 h time points were compared for Mist1 in Table 4, very 
little change was evident, and what change was noticeable was actually a 
decrease in methylation. CpG site #5 remained unmethylated in every sample 
throughout this study, regardless of time elapsed. Besides site #5, only one 
Mist1 CpG site, #19, in only one sample, registered as being unmethylated at the 
o h time point. However, after 18 h had passed, CpG sites # 3, 6, 11, 14, 16, and 
19 were also unmethylated in at least one sample. Site #11 was the only site to 
appear as unmethylated in more than one sample. 
Although the number and location of unmethylated CpG sites increased 
over time, the expression level of Mist1 continued to decrease. This is contrary 
to the statement by Jones and Laird in 1999, that a decrease in methylation over 
time may posses the potential for up-regulating a gene [58]. These findings 
demonstrate that the loss of expression of Mist1 , which does have a CpG island 
present in its promoter region, is not due to an increase in methylation of this 
island. This is contrary to my hypothesis, and there are at least 4 possible 
explanations for this: the Mist1 gene may have other CpG islands outside the 
4,000 bp region I examined; the Mist1 gene may be regulated by individual 
critical CpG sites, as discussed below; a different transcription factor gene which 
regulates Mist1 expression may be regulated by methylation; or DNA methylation 
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may have no direct role in repression of Mist1 expression during culture of 
parotid acinar cells. 
Currently, there are two viewpoints on DNA methylation: one thought is 
that a global increase of methylation at CpG sites is necessary to affect 
expression, which is what was tested in this study. The other opinion is that it is 
not dependent on a global increase, but that the epigenetic control comes from 
specific, individual independent CpG sites [42]. There are CpG sites in areas of 
the Mist1 promoter region that are not located in the CpG island itself, and one or 
more of those sites could be the sites that affect expression. CpG sites like site 
#5 in the Mist1 CpG island that remained unmethylated in each sample, 
regardless of time passed, indicate that the methylation status of the individual 
sites is not random. There could certainly be CpG sites elsewhere in the 
promoter region that show consistent unmethylated statuses at early time points, 
and those could lead to finding which of those sites consistently became 
methylated over time. Further studies of the Mist1 promoter region are 
necessary, but currently my data demonstrate that global methylation of the CpG 
island in the promoter region of Mist1 is not the cause of decreased expression 
and dedifferentiation. 
The PSP gene lacks any clear CpG islands, but it does contain scattered 
individual CpG sites. Methylation of such individual CpG sites has recently been 
suggested to be able to regulate gene expression. In contrast to the Mist1 gene, 
PSP showed a predominantly unmethylated state for the seven CpG sites near 
the transcription start site. 
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PSP was initially developed as the negative control due to its lack of CpG 
islands and the subsequent rarity of CpG sites near the transcription site, but it 
did not turn out to be a control in the sense of having no change in methylation 
status. Of the sites sequenced for PSP, 20% are methylated in the gland 
samples compared to 65.4% in the 0 h samples, which is more than a three-fold 
increase. The fact that many of the sites were methylated at the 0 h time point, 
whereas very few were methylated in the gland samples taken 3 hours before 
that (2 hours for digestion with collagenase, and 1 hour for plating fibroblasts), 
could indicate that the methylation response is fairly rapid. Furthermore, 
comparing the 0 hand 18 h time pOints for PSP in Table 5 shows a continued 
increase in methylation over time, from 65.4% at 0 h to 84.6% at 18 h, which 
corresponds to my hypothesis. If the 20% methylated state seen in the gland 
samples is also considered, there is a significant increase in methylation over 
time, which correlates with the dramatic decrease in expression of PSP that is 
seen in the first twenty-four hours of culture. Although PSP is lacking a CpG 
island, and the number of CpG sites near the transcriptional start site is 
considerably lower than what is seen in Mist1, there could certainly still be a link 
between methylation of the CpG sites that are present and the loss of 
expression. 
The correlation seen in PSP between the passage of time, the increase in 
methylation, and the decrease in expression agrees with my hypothesis. 
However, as mentioned, PSP did not have a CpG island. This may be an 
example of a gene where methylation of individual CpG sites control the loss of 
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expression, as opposed to global methylation changes. Again, further 
investigation of the promoter region of the PSP gene should be pursued to 
evaluate more CpG sites, but the sites evaluated in this study should definitely be 
considered as possible controlling sites, as there was a positive correlation with 
their methylation status and the loss of expression. 
In conclusion, significant differences were not seen between levels of 
methylation in gland cells compared to cultured parotid cells for Mist1, which 
indicates that methylation of the CpG island in the Mist1 promoter region 
evaluated in this study is not a controlling factor in expression. There may be, 
however, other CpG islands outside of the 4,000 bp area examined here that 
playa controlling role in the expression of Mist1. Significant differences were 
seen between levels of methylation gland cells compared to cultured parotid cells 
for Parotid Secretory Protein, which supports the theory that epigenetic control of 
PSP expression is present. Further testing of both Mist1 and PSP should be 
completed before a true correlation is drawn, but this study is evidence that may 
contribute to the theory that individual CpG sites in the promoter regions are 
where epigenetic control occurs in the PSP gene. Overall, this experiment 
suggests that global DNA methylation is not the cause of de-differentiation of 
parotid acinar cells in culture, which is contrary to my hypothesis, but it does 
indicate that increases in methylation at individual CpG sites seen over time may 
well correlate to decreases in expression for the PSP gene. 
Future studies to further elucidate the role of DNA methylation in 
controlling expression of PSP will require different approaches than those used in 
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this study. The recognition that epigenetic silencing may playa major role in 
tumor biology has led to studies involving demethylating agents, such as DNA 
methyltransferase inhibitor 5-aza-2'-deoxycytidine (decitabine) [52]. 
Demethylating agents like decitabine may be employed in the continued study of 




1. Saracco CG and Crabill EV: Anatomy of the human salivary gland, in 
Biology ofthe Salivary Glands. Dobrosielski-Vergona K, Ed., CRC Press, 
Boca Raton, 1993, 1-7 
2. Hand AH: Salivary Glands, in Orban's Oral Histology and Embryology. 
Bohaskar SN, Ed., Mosby CV, St. Louis, 1986, 354 
3. Weihong Y, Apweilaer R, Wong DT et. a/:Systematic comparison of the 
human saliva and plasma proteoms. Proteomics - Clinical Applications 
2008, 3(1): 116-134 
4. Pinkstaff CA: Cytology, histology, and histochemistry of salivary glands: 
an overview, in Biology of the Salivary Glands. Dobrosielski-Vergona K, 
Ed., CRC Press, Boca Raton, 1993, 17-19 
5. Yound JA and Van Lennep EW: The morphology of salivary glands. 
Academic Press, London, 1978, 44-47 
6. MandellD: The functions of saliva. J Dent Res. 1987, (66):623-627 
7. Ericsson Y: Clinical Investigations of the Salivary Buffering Action. Acta 
Odontologica Scandinavica 1959, 17(2):131-165 
8. Etzel KR: The functions of saliva in the human body, in Biology of the 
Salivary Glands. Dobrosielski-Vergona K, Ed., CRC Press, Boca Raton, 
1993, 1-7 
9. Fox RI, Tornwall J, Michelson P: Current issues in the diagnosis and 
treatment of Sjogren's syndrome. Current Opinion in Rheumotology 1999, 
11 :364-371 
10. Andoh Y, Shimura S, Sawai T, Sasaki H, Takishima T, Shirato K: 
Morphometric analysis of secretory glands in Sjogren's syndrome. Am 
Rev Respir Dis 1993, 148:1385-1362 
11. Daniels T, Fox PC: Salivary and oral components of Sjogren's syndrome. 
Rheum Dis Clin North Am 1992, 18:571-589 
12. Daniels TE: Sjogren's syndrome: Clinical spectrum and current diagnostic 
controversies. Adv. Dent. Res. 1996, 10:3-8 
13. Daniels TE, Silverman S, Michalski JP, Greenspan JS, Sylvester RA, Talal 
N: The oral components of Sjogren's syndrome. Oral Surg Oral Med Oral 
Pathol 1975, 39:875-885 
14. Wood N, Goaz P: Differential Diagnosis of Oral and Maxillofacial Lesions, 
5th Edition, 1997, Mosby-Year Book, Inc. pp. 99-101 
15. Cooper JS, Fu K, Markes J: Late effects of raditation therapy in the head 
and neck region. Int J Radiation Oncology Bioi Phys 1995, 5: 1141-1164 
63 
16. Woods JE, Guan CC, Oliver HB: Experience with 1,360 primary parotid 
tumors. American Journal of Surgery 1975, 4:460-462 
17. Greenberg M, Glick M, and Ship J: Burket's Oral Medicine, 11th edition, 
2008. BC Decker, Inc., pp. 192-200 
18. Soto-Rojas AE, Villa AR, Sifuentes-Osornio J, Alarcon-Segovia D, Kraus 
A: Oral manifestations in patients with Sjogren's syndrome. J Rheumatol 
1998, 25:906-910 
19. Vitali C, Moutsopoulos HM, Bombardieri S: The european community 
study group on diagnostic criteria for Sjogren's syndrome. sensitivity and 
specificity of tests for ocular and oral involvement in Sjogren's syndrome. 
Ann Rheum Dis 1994, 53:637-647 
20. Soto-Rojas AE, Villa AR, Sifuentes-Osornio J, Alarcon-Segovia D, Kraus 
A: Oral candidiasis and Sjogren's syndrome. J Rheumotol 1998, 25:911-
915 
21. Almstahl A, Kroneld U, Tarkowski A, Wikstsrom M: Oral microbial flora in 
Sjogren's syndrome. J Rheumotol1999, 26:110-114 
22. Hernandez Yl, Daniels TE: Oral candidiasis in Sjogren's syndrome: 
prevalence, clinical correlations, and treatment. Oral Surg Oral Med Oral 
Pathol 1989, 68:324-329 
23. Gorr SU, Venkatesh SG, and Darling DS, Parotid Secretory Granules: 
Crossroads of Secretory Pathways and Protein Storage. J Dent. 2005, 
Res.; 84: 500 - 509. 
24. lombaert IMA, Brunsting JF, Wierenga PK, Faber H, Stokman MA, et a/: 
Rescue of salivary gland function after stem cel/ transplantation in 
irradiated glands. PloS ONE 2008, 3(4): e2063 
25. Quissell DO, Redman RS, Barzen KA, et al.: Effects of oxygen, insulin, 
and glucagon concentration on rat submandibular acini in serum-fee 
primary culture. In Vitro Cell Develop Bioi 1994. 30A:833-842 
26. Pin Cl, Bonvissuto AC, and Konieczny SF: Mist1 expression is a common 
link among serous exocrine cel/s exhibiting regulated exocytosis. The 
Anatomical Record 2000, 259: 157 -167 
27. Shaw P and Schibler U: Structure and expression ofthe parotid secretory 
protein gene of mouse. Journal of Molecular Biology 1986, 192(3):567-576 
28. Meisler MH and Ting CN: The remarkable evolutionary history of the 
human amylase genes. Crit. Rev. Oral BioI. Med 1993, 4:503-509 
29. Zheng C, Hoffman MP, McMillan T, Kleinman HK, and O'Connell BC: 
Growth factor regulation of the amylase promoter in a differentiating 
salivary acinar cel/line. Journal of Cellular Physiology 1998, 177:628-635 
30. Bockman CS, Bradley ME, Dang HK, Zeng W, Scofield MA, and Dowd FJ: 
Molecular and pharmacological characterization of muscarinic receptor 
subtypes in a rat parotid gland cel/line: Comparison with native parotid 
gland. Journal of Pharmacology and Experimental Therapeutics 2001, 
297:718-726 
31. Quissell DO, Barzen KA, Redman RS, Camden JM, and Turner JT: 
Development and characterization of SV40 immoratlized rat parotid acinar 
cel/lines. In Vitro Cell Develop Bioi 1998, 34:58-67 
64 
32. Turner JT, Redman RS, Camden JM, Landon LA, and Quissell DO: A rat 
parotid gland cell line, Par-C10, exhibits neurotransmitter-regulated 
transepithelial anion secretion. Am J Physiol Cell Physiol 1998, 275:367-
374 
33. Humphries MJ, Limesand KH, Schneider JC, Nakayama KI, Anderson 
SM, and Reyland ME: Suppression of Apoptosis in the Protein Kinase C 
Null Mouse in Vivo. J. BioI. Chem. 2006, 281 :9728 - 9737. 
34. Yoshigaki J, Tagashira A, Yoshigaki T, Furuyama S, and Sugiya H: A 
primary culture of parotid acinar cells retaining capacity for agonists-
induced amylase secretion and generation of new secretory granules. Cell 
Tissue Res 2005; 320,(3):455-464 
35. Zhu Y, Aletta JM, Wen J, Zhang X, Higgins D, and Rubin RP: Rat serum 
Induces a differentiated phenotype in a rat parotid acinar cell line. 
American Journal of Physiology-Gastrointestinal and Liver Physiology 
1998, 275:259-268 
36. Barros SP, and Offenbacher S: Epigenetics: Connecting environment and 
genotype to phenotype and disease. J Dent Res. 2009, 88(5):400-408 
37. Bachman AN, Curtin GM, Doolittle DJ, and Goodman JI: Altered 
methylation in gene-specific and GC-rich regions of DNA is progressive 
and nonrandom during promotion of skin tumorigenesis. Toxicological 
Sciences 2006, 91 (2):406-418 
38. Youngson RM: Collins Dictionary of Human Biology. Glasgow: 
HarperCollins. 2006. 
39. Cox M, Nelson DR, Lehninger AL: Lehninger Principles of Biochemistry. 
San Francisco: W.H. Freeman 2005 
40. Redon C, Pilch D, Rogakou E, Sedelnikova 0, Newrock K, Bonner W: 
Histone H2A variants H2AX and H2AZ. Curro Opin. Genet. Dev. 2002. 12 
(2):162-9 
41. Errol C. Friedberg (February 2006). "Timeline: The eureka enzyme: the 
discovery of DNA polymerase". Nature Reviews Molecular Cell Biology 7 
(2): 143-7 
42. Bird A: DNA methylation patterns and epigenetic memory; Genes & Dev. 
2002,16: 6. 
43. Fouse SD, Shen Y, Pellegrini M, Cole S, Meissner A, Van Neste L, 
Jaenisch, and Fan G: Promoter CpG methylation contributes to ES cell 
gene reulation in parallel with Oct4lNanog, PcG complex, and histone H3 
K41K27 trimethylation. Cell Stem Cell 2008, 160-169 
44. Feng J, Fouse S, Fan G: Epigenetic regulation of neural gene expression 
and neuronal function. Pediatr. Res. 2007, 61: 58R-63R 
45. Jaenisch R, and Bird A: Epigenetic regulation of gene expression: how the 
genome integrates intrinsic and environmental signals. Nat. Genet. Suppl. 
2003, 33: 245-254 
46. Li E: Chromatin modiication and epigenetic reprogramming in mammalian 
development. Nat. Rev. Genet. 2002, 3: 662-673 
47. Robertson KD: DNA methylation and human disease. Nat. Rev. Genet. 
2005,6:597-610 
65 
48. Hark AT, Schoenherr CJ, Katz OJ, Ingram RS, Levorse JM, and Tilghman 
SM: CTCF mediates methylation-sensitive enhancer-blocking activity of 
the H19/lgf2 locus. Nature 2000, 405:486-489 
49. Loenen WA: S-adenosylmethionine: jack of all trades and master of 
everything? Biochem Soc Trans 2006, 34(Pt 2):330-333 
50. Shen L, Kondo Y, Guo Y, Zhang J, Zhang L, et a/: Genome-wide profiling 
of methylation reveals a class of normally methylated CpG island 
promoters. PLoS Genet 2007, 3(1 0):e181.doi:1 0.1371 
51. Bird AP: CpG-rich islands and the function of DNA methylation. Nature 
1986, 321 :209-213 
52. Rubenstein JC, Tran N, Ma S, Halaban R, and Krauthammer M: Genome-
wide methylation and expression profiling identifies promoter 
characterstics affecting demethylation-induced gene up-regulation in 
melanoma. BMC Medical Genomics 2010,3:4 
53. Martin V, Jorgensen H, Chaubert A, Berger J, Barr H, Shaw P, Bird A, 
Chaubert P: MBD2-mediated transcriptional repression of the p14ARF 
tumor suppressor gene in human colon cancer cells. Pathobiology 2008, 
75(5):281-287 
54. Barr H, Hermann A, Berger J, Tsai H, Adie K, Prokhortchouk A, Hendrich 
B, Bird A: MBD2 contributes to DNA methylation-directed repression of the 
xist gene. Mol Cell Bioi 2007, 27(10):3750-3757 
55. Bird AP and Wolffe AP: Methylation-induced repression: beltes, braces, 
and chromatin. Cell 1999, 99:451-454 
56. Bestor T: Gene silencing. Methylation meets acetylation. Nature 1998, 
393(6683):311-312 
57. Iguchi-Ariga S and Schaffner W: CpG methylation of the camp-responsive 
enhancer/promoter sequence TGACGTCA abolishes specific factor 
binding as well as transcriptional activation. Genes Dev 1989, 3(5):612-
619 
58. Jones PA and Laird PW: Cancer epigenetics comes of age. Nature Genet. 
1999,21 :163-167 
59. Taylor SM and Jones PA: Multiple new phenotypes induced in 10T1/2-
cells and 3T3-cells treated with 5-azacytidine. Cell 1979, 17:771-779 
60. Frommer M, et al.: Comparative methylation analysis of CpG islands in 
man and mouse. PNAS 1992,89:1827-1831 
61. Clark SJ, Harrison J, Paul CL, and Frommer M: High sensitivity mapping 
of methylated cytosines. Nucleic Acids Res. 1994, 22(15):2990-2997 
62. Ambatipudi KS, Lu B, Hagen FK, Melvin JE, and Yates III JR: Quantitative 
analysis of age specific variation in the abundance of human female 
parotid salivary proteins. Journal of Proteome Research 2009, 5093-5102 
63. Kaplan MD and Baum BJ: The functions of saliva. Dysphagia 1993, 
8(3):225-229 
64. Vucic EA, Brown CJ, Lam WL: Epigenetics of cancer progression. 
Pharmacogenomics 2008, 9:215-234 
65. Larsen F, Gundersen G, Lopez R, and Prydz H: CpG islands as gene 
markers in the human genome. Genomics 1992, 13:1095-1107 
66 
66. Saxonov S, Berg P, Brutlag DL: A genome-wide analysis of CpG 
dinucleotides in the human genome distinguishes two distinct classes of 
promoters. Proc Natl Acad Sci USA 2006.103(5):1412-1417 
67. Tarze A, Deniaud A, le Bras M, Maillier E, Molle 0, larochette N, 
Zamzami N, Jan G, Kroemer G, and Brenner, C: GAPDH, a novel 
regulator of the pro-apoptotic mitochondrial membrane permeabi/ization. 
Oncogene 2007.26(18):2606-2620 
68. Cheung P, and lau P: Epigenetic Regulation by Histone Methylation and 
Histone Variants. Molecular Endocrinology 2005. 19:563- 573 
69. Feil R, Berger, F: Convergent evolution of genomic imprinting in plants 
and mammals. Trends Genet 2007.23(4):192-199 
70. Caruso AJ, Sonies BC, Atkinson JC, Fox PC: Objective measures of 
swallowing in patients with primary Sjogren's syndrome. Dysphagia 1989, 
4: 101-105 
71. Chudwin OS, Daniels TE, Wara OW, Ammann AJ, Barrett OJ, Whitcher 
JP, et al.: Spectrum of Sjogren's syndrome in children. J Pediatr 1981, 
98:213-217 
72. Daniels TE, Whitcher JP: Association of patterns of labial salivary gland 
inflammation with keratoconjunctivitis sicca. Analysis of 618 patients with 
suspected Sjogren's syndrome. Arthritis Rheum 1994,37:869-877 
73. lachner M, O'Sullivan R.J., and Jenuwein T: An epigenetic road map for 
histone lysine methylation. J. Cell Sci. Jun 2003, 116:2117 - 2124 
74. Pin Cl, Rukstalis, JM, Johnson C, and Konieczny SF: The bHLH 
transcription factor Mist1 is required to maintain exocrine pancreas cell 
organization and acinar cell identity. J. Cell BioI. 2001, 155:519 
67 
LIST OF ABBREVIATIONS 
EGF - Epithelial growth factor 
RA - Retinoic acid 
T 3 - Triiodothyronine 
FGF - Fibroblast growth factor 
ITS - X - Insulin, transferrin, and selenium mixture 
ELISA - Enzyme-linked immunosorbent assay 
PBS - Phosphate buffered saline 
TNF - Tumor necrosis factor 
HBSS - Hank's Buffered Salt Solution 
BSA - Bovine Serum Albumin 
PBS - Phosphate buffered saline 
GAPDH - Glyceraldehyde 3-phosphate dehydrogenase 
TCF12 - Transcription Factor 12 
SCM - Standard Control Media 
RSM - Rat Serum Medium 
CRS - Cystatin/Rat Serum Medium 
RFT - RA/FGF/Trace Element Medium 
CpG - Cytosine-Guanine dinucleotide 
MBD - Methyl-CpG-binding domain proteins 
PCR - Polymerase Chain Reaction 
h - Hours 
bp - Base pairs 
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